SAGE Therapeutics's market cap is currently ―. The company's EPS TTM is $-9.926; its P/E ratio is -2.07; SAGE Therapeutics is scheduled to report earnings on November 7, 2023, and the estimated EPS forecast is $-2.65. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 2.46M	$ 3.29M	$ 2.86M	$ 1.74M	$ 1.50M
Gross Profit	$ 2.47M	$ 3.29M	$ 2.86M	$ 1.55M	$ 1.30M
EBIT	$ -159.91M	$ -155.66M	$ -153.94M	$ -141.48M	$ -128.41M
EBITDA	$ -159.58M	$ -155.34M	$ -153.67M	$ -141.20M	$ -128.13M
Net Income Common Stockholders	$ -160.32M	$ -146.83M	$ -147.15M	$ -137.32M	$ -126.26M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.00B	$ 1.13B	$ 1.27B	$ 1.39B	$ 1.51B
Total Assets	$ 1.08B	$ 1.22B	$ 1.35B	$ 1.49B	$ 1.60B
Total Debt	$ 8.73M	$ 10.45M	$ 12.13M	$ 13.77M	$ 15.36M
Net Debt	$ -993.89M	$ -1.12B	$ -1.26B	$ -1.38B	$ -1.50B
Total Liabilities	$ 97.91M	$ 87.56M	$ 1.38B	$ 105.95M	$ 97.14M
Stockholders Equity	$ 984.38M	$ 1.13B	$ 1.28B	$ 1.38B	$ 1.50B
Cash Flow	-
Free Cash Flow	$ -131.63M	$ -153.91M	$ -127.24M	$ -119.23M	$ -106.56M
Operating Cash Flow	$ -131.52M	$ -153.68M	$ -126.95M	$ -118.86M	$ -106.44M
Investing Cash Flow	$ 45.59M	$ 194.87M	$ 89.78M	$ 110.95M	$ 134.26M
Financing Cash Flow	$ 847.00K	$ 2.67M	$ 29.00K	$ 1.23M	$ 13.00K

Currency in USD

SAGE Therapeutics Earnings and Revenue History

Income Statement >

SAGE Therapeutics Debt to Assets

Balance Sheet >

SAGE Therapeutics Cash Flow

Cash Flow >

SAGE Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing